Hepatitis C virus and cardiovascular: A review

Salvatore Petta1

  • 1Sezione di Gastroenterologia, Dipartimento Biomedico di Medicina Interna e Specialistica, Piazza delle Cliniche, 2, 90127 Palermo, Italy.

Insights

Chronic hepatitis C virus (HCV) infection may increase cardiovascular risk. Further research is needed to confirm this link and the benefits of HCV treatment on heart health.

Area of Science:

  • Hepatology
  • Cardiology
  • Virology

Background:

  • Chronic hepatitis C virus (HCV) infection is a systemic illness linked to cirrhosis, extrahepatic disorders, and metabolic issues like insulin resistance.
  • Emerging evidence suggests a connection between HCV infection and increased cardiovascular risk, with potential benefits from viral eradication.
  • However, conflicting data and the high prevalence of both conditions create uncertainty regarding a direct association.

Purpose of the Study:

  • To review existing data on the relationship between HCV infection and cardiovascular risk.
  • To explore potential mechanisms linking HCV to vascular damage.
  • To assess the impact of HCV viral eradication on cardiovascular outcomes.

Main Methods:

  • Systematic review of current literature.
  • Analysis of studies investigating HCV infection and cardiovascular alterations.
  • Evaluation of evidence on mechanisms and outcomes of HCV treatment.

Main Results:

  • Accumulating evidence suggests HCV infection may elevate cardiovascular risk.
  • Potential mechanisms linking HCV to vascular damage have been identified.
  • Conflicting results exist, necessitating further investigation.

Conclusions:

  • The precise role of HCV in cardiovascular alterations requires definitive clarification.
  • The impact of viral eradication on cardiovascular outcomes needs further study.
  • New, effective antiviral therapies make this research timely.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
304
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
245
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
633
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
851